| RS2504425233 |
TECPR2
|
Health Risk |
Pathogenic |
Hereditary spastic paraplegia 49, Hereditary spastic paraplegia 49 |
| RS2504425268 |
TECPR2
|
Health Risk |
Likely pathogenic |
Hereditary spastic paraplegia 49, Hereditary spastic paraplegia 49 |
| RS2504432690 |
TECPR2
|
Health Risk |
Pathogenic |
Hereditary spastic paraplegia 49, Hereditary spastic paraplegia 49 |
| RS2504432999 |
TECPR2
|
Health Risk |
Pathogenic |
Hereditary spastic paraplegia 49, Hereditary spastic paraplegia 49 |
| RS2504433132 |
TECPR2
|
Health Risk |
Likely pathogenic |
Hereditary spastic paraplegia 49, Hereditary spastic paraplegia 49 |
| RS2504437253 |
TECPR2
|
Health Risk |
Pathogenic |
Hereditary spastic paraplegia 49, Hereditary spastic paraplegia 49 |
| RS2504446168 |
TECPR2
|
Health Risk |
Pathogenic |
Hereditary spastic paraplegia 49, Hereditary spastic paraplegia 49 |
| RS2504446531 |
TECPR2
|
Health Risk |
Likely pathogenic |
Hereditary spastic paraplegia 49, Hereditary spastic paraplegia 49 |
| RS2504446543 |
TECPR2
|
Health Risk |
Likely pathogenic |
Hereditary spastic paraplegia 49, Hereditary spastic paraplegia 49 |
| RS2504453043 |
TECPR2
|
Health Risk |
Pathogenic |
Hereditary spastic paraplegia 49, Hereditary spastic paraplegia 49 |
| RS2504453415 |
TECPR2
|
Health Risk |
Pathogenic |
Hereditary spastic paraplegia 49, Hereditary spastic paraplegia 49 |
| RS2504458939 |
TECPR2
|
Health Risk |
Pathogenic |
Hereditary spastic paraplegia 49, Hereditary spastic paraplegia 49 |
| RS2504459163 |
TECPR2
|
Health Risk |
Pathogenic |
Hereditary spastic paraplegia 49, Hereditary spastic paraplegia 49 |
| RS2504459355 |
TECPR2
|
Health Risk |
Pathogenic |
Hereditary spastic paraplegia 49, Hereditary spastic paraplegia 49 |
| RS2504476908 |
OTUD7A
|
Health Risk |
Pathogenic |
Neurodevelopmental disorder with hypotonia and seizures, Neurodevelopmental disorder with hypotonia and seizures |
| RS2504480471 |
TECPR2
|
Health Risk |
Pathogenic |
Hereditary spastic paraplegia 49, Hereditary spastic paraplegia 49 |
| RS2504480577 |
TECPR2
|
Health Risk |
Pathogenic |
Hereditary spastic paraplegia 49, Hereditary spastic paraplegia 49 |
| RS2504484068 |
ATL1
|
Health Risk |
Likely pathogenic |
Hereditary spastic paraplegia 3A, Hereditary spastic paraplegia 3A |
| RS2504488763 |
CEP152
|
Health Risk |
Pathogenic |
Microcephaly 9, primary |
| RS2504488840 |
CEP152
|
Health Risk |
Pathogenic |
— |
| RS2504489626 |
CEP152
|
Health Risk |
Pathogenic |
— |
| RS2504489983 |
PHF21A
|
Health Risk |
Pathogenic |
Intellectual developmental disorder with behavioral abnormalities and craniofacial dysmorphism with or without seizures, Intellectual developmental disorder with behavioral abnormalities and craniofacial dysmorphism with or without seizures |
| RS2504492104 |
ATL1
|
Health Risk |
Pathogenic |
Hereditary spastic paraplegia 3A, Hereditary spastic paraplegia 3A |
| RS2504492333 |
ATL1
|
Health Risk |
Likely pathogenic |
— |
| RS2504493603 |
ATL1
|
Health Risk |
Likely pathogenic |
Hereditary spastic paraplegia 3A, Hereditary spastic paraplegia 3A |
| RS2504493819 |
ATL1
|
Health Risk |
Likely pathogenic |
Hereditary spastic paraplegia 3A, Hereditary spastic paraplegia 3A |
| RS2504503924 |
ATL1
|
Health Risk |
Pathogenic |
Hereditary spastic paraplegia 3A, Hereditary spastic paraplegia 3A |
| RS2504510600 |
MAX
|
Health Risk |
Pathogenic |
Hereditary pheochromocytoma and paraganglioma, Hereditary pheochromocytoma and paraganglioma |
| RS2504523105 |
TECPR2
|
Health Risk |
Pathogenic |
Hereditary spastic paraplegia 49, Hereditary spastic paraplegia 49 |
| RS2504524056 |
EIF2AK4
|
Health Risk |
Pathogenic |
Pulmonary arterial hypertension, Pulmonary arterial hypertension |
| RS2504524090 |
RAD51
|
Health Risk |
Likely pathogenic |
Fanconi anemia complementation group R, Fanconi anemia complementation group R |
| RS2504531661 |
EIF2AK4
|
Health Risk |
Pathogenic |
— |
| RS2504532073 |
RAD51
|
Health Risk |
Likely pathogenic |
Fanconi anemia complementation group R, Fanconi anemia complementation group R |
| RS2504535639 |
MEIS2
|
Health Risk |
Pathogenic |
— |
| RS2504536056 |
MEIS2
|
Health Risk |
Likely pathogenic |
Cardiac malformation, cleft lip/palate |
| RS2504537554 |
EIF2AK4
|
Health Risk |
Likely pathogenic |
EIF2AK4-related disorder, EIF2AK4-related disorder |
| RS2504539104 |
GCH1
|
Health Risk |
Pathogenic |
Dystonia 5, GTP cyclohydrolase I deficiency |
| RS2504539343 |
GCH1
|
Health Risk |
Likely pathogenic |
Dystonia 5, GTP cyclohydrolase I deficiency |
| RS2504539350 |
GCH1
|
Health Risk |
Conflicting classifications of pathogenicity |
Dystonia 5, GTP cyclohydrolase I deficiency |
| RS2504539432 |
GCH1
|
Health Risk |
Likely pathogenic |
GTP cyclohydrolase I deficiency with hyperphenylalaninemia, GTP cyclohydrolase I deficiency with hyperphenylalaninemia |
| RS2504540200 |
GCH1
|
Health Risk |
Pathogenic |
Dystonia 5, GTP cyclohydrolase I deficiency |
| RS2504540656 |
ATL1
|
Health Risk |
Likely pathogenic |
Hereditary spastic paraplegia, Hereditary spastic paraplegia |
| RS2504541515 |
GCH1
|
Health Risk |
Pathogenic |
Dystonia 5, GTP cyclohydrolase I deficiency |
| RS2504560447 |
ATL1
|
Health Risk |
Likely pathogenic |
Hereditary spastic paraplegia 3A, Hereditary spastic paraplegia 3A |
| RS2504560480 |
ATL1
|
Health Risk |
Pathogenic |
Hereditary spastic paraplegia 3A, Hereditary spastic paraplegia 3A |
| RS2504564381 |
EIF2AK4
|
Health Risk |
Likely pathogenic |
EIF2AK4-related disorder, EIF2AK4-related disorder |
| RS2504564383 |
ATL1
|
Health Risk |
Pathogenic |
Hereditary spastic paraplegia 3A, Hereditary spastic paraplegia 3A |
| RS2504567974 |
SLC24A5
|
Health Risk |
Pathogenic |
— |
| RS2504568018 |
SLC24A5
|
Health Risk |
Likely pathogenic |
— |
| RS2504569305 |
SLC24A5
|
Health Risk |
Pathogenic |
— |
| RS2504569936 |
EIF2AK4
|
Health Risk |
Pathogenic |
— |
| RS2504570367 |
CEP152
|
Health Risk |
Pathogenic |
— |
| RS2504572059 |
CEP152
|
Health Risk |
Likely pathogenic |
— |
| RS2504573137 |
EIF2AK4
|
Health Risk |
Likely pathogenic |
Familial pulmonary capillary hemangiomatosis, Familial pulmonary capillary hemangiomatosis |
| RS2504577269 |
ATL1
|
Health Risk |
Likely pathogenic |
Hereditary spastic paraplegia 3A, Hereditary spastic paraplegia 3A |
| RS2504577368 |
ATL1
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary spastic paraplegia 3A, Hereditary spastic paraplegia 3A |
| RS2504577780 |
ATL1
|
Health Risk |
Pathogenic |
Hereditary spastic paraplegia 3A, Hereditary spastic paraplegia 3A |
| RS2504578020 |
ATL1
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary spastic paraplegia 3A, Hereditary spastic paraplegia 3A |
| RS2504592443 |
SLC24A5
|
Health Risk |
Likely pathogenic |
— |
| RS2504595149 |
SLC24A5
|
Health Risk |
Likely pathogenic |
— |
| RS2504597755 |
SLC24A5
|
Health Risk |
Pathogenic |
Oculocutaneous albinism type 6, Oculocutaneous albinism type 6 |
| RS2504598048 |
SLC24A5
|
Health Risk |
Pathogenic |
— |
| RS2504598589 |
CEP152
|
Health Risk |
Likely pathogenic |
— |
| RS2504600107 |
CEP152
|
Health Risk |
Pathogenic |
— |
| RS2504602075 |
CEP152
|
Health Risk |
Pathogenic/Likely pathogenic |
CEP152-related disorder, Microcephaly 9 |
| RS2504607374 |
CEP152
|
Health Risk |
Pathogenic |
— |
| RS2504609565 |
EIF2AK4
|
Health Risk |
Pathogenic |
— |
| RS2504624158 |
ZMYM2
|
Health Risk |
Likely pathogenic |
— |
| RS2504627688 |
SLC24A5
|
Health Risk |
Pathogenic |
— |
| RS2504639204 |
EIF2AK4
|
Health Risk |
Pathogenic |
— |
| RS2504641181 |
CEP152
|
Health Risk |
Pathogenic |
— |
| RS2504642290 |
CEP152
|
Health Risk |
Pathogenic |
— |
| RS2504643899 |
AP4E1
|
Health Risk |
Likely pathogenic |
Developmental disorder, Developmental disorder |
| RS2504661616 |
CEP152
|
Health Risk |
Pathogenic |
— |
| RS2504662186 |
CEP152
|
Health Risk |
Pathogenic |
— |
| RS2504663889 |
CEP152
|
Health Risk |
Pathogenic |
— |
| RS2504664282 |
CEP152
|
Health Risk |
Likely pathogenic |
— |
| RS2504680805 |
SORD
|
Health Risk |
Pathogenic |
— |
| RS2504691114 |
AP4E1
|
Health Risk |
Likely pathogenic |
Spastic paraplegia, Spastic paraplegia |
| RS2504699867 |
CEP152
|
Health Risk |
Likely pathogenic |
— |
| RS2504700478 |
CEP152
|
Health Risk |
Pathogenic |
— |
| RS2504702178 |
SORD
|
Health Risk |
Likely pathogenic |
Neuronopathy, distal hereditary motor |
| RS2504713247 |
CEP152
|
Health Risk |
Likely pathogenic |
— |
| RS2504713538 |
CEP152
|
Health Risk |
Likely pathogenic |
Microcephaly 9, primary |
| RS2504718500 |
SORD
|
Health Risk |
Pathogenic |
Neuronopathy, distal hereditary motor |
| RS2504721465 |
CEP152
|
Health Risk |
Pathogenic |
— |
| RS2504721725 |
CEP152
|
Health Risk |
Pathogenic |
— |
| RS2504721792 |
CEP152
|
Health Risk |
Likely pathogenic |
— |
| RS2504726611 |
SERPINA1
|
Health Risk |
Likely pathogenic |
Alpha-1-antitrypsin deficiency, Alpha-1-antitrypsin deficiency |
| RS2504728206 |
SERPINA1
|
Health Risk |
Likely pathogenic |
Alpha-1-antitrypsin deficiency, Alpha-1-antitrypsin deficiency |
| RS2504735219 |
DUOX2
|
Health Risk |
Likely pathogenic |
— |
| RS2504736239 |
DUOX2
|
Health Risk |
Pathogenic |
— |
| RS2504737520 |
DUOX2
|
Health Risk |
Pathogenic |
— |
| RS2504737542 |
DUOX2
|
Health Risk |
Pathogenic |
— |
| RS2504738840 |
DUOX2
|
Health Risk |
Likely pathogenic |
Thyroid dyshormonogenesis 6, Thyroid dyshormonogenesis 6 |
| RS2504740195 |
DUOX2
|
Health Risk |
Pathogenic |
— |
| RS2504740238 |
DUOX2
|
Health Risk |
Pathogenic |
— |
| RS2504740514 |
DUOX2
|
Health Risk |
Pathogenic |
— |
| RS2504740629 |
DUOX2
|
Health Risk |
Pathogenic |
— |
| RS2504743262 |
CEP152
|
Health Risk |
Pathogenic |
— |